ClinicalTrials.Veeva

Menu

Effects of Resistance and Endurance Training in Pediatric Cancer Patients During Intensive Treatment Phase (MUCKI)

J

Johannes Gutenberg University (JGU)

Status

Completed

Conditions

Pediatric Oncology

Treatments

Behavioral: Exercise Training

Study type

Interventional

Funder types

Other

Identifiers

NCT02612025
Mucki01

Details and patient eligibility

About

The purpose of this study is to determine whether combined endurance and resistance training can improve muscle strength in children and adolescents with cancer during the intensive treatment phase.

Enrollment

35 patients

Sex

All

Ages

4 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Malignant Tumor
  • Medical Treatment in the Center for Pediatrics, Hematology, Oncology and Hemostaseology Mainz (Germany)
  • > 3 years
  • Signed Informed Consent

Exclusion criteria

  • Functional and/or cognitive limitations which limit performance during training
  • Orthopedic condition which hinders to adequately participate in exercise training
  • Heart failure (NYHA III-IV)
  • Partial or global respiratory failure
  • Symptomatic coronary disease
  • Serious therapy-refractory hypertonia
  • Sustainable thrombocytopenia <10.000/µl, f. ex. therapy-refractory autoimmune thrombocytopenia
  • Hereditary or acquired thrombocytopenia or coagulation disturbance
  • Uncontrolled cerebral spasm
  • CNS metastases
  • Medical or psychological condition which does in the doctors opinion not allow participation in sport activity

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

35 participants in 2 patient groups

Exercise group
Experimental group
Description:
Exercise training during intensive medical treatment
Treatment:
Behavioral: Exercise Training
Control group
No Intervention group
Description:
Usual Care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems